Emphysematous cystitis: a review of the literature

M Amano, T Shimizu - Internal medicine, 2014 - jstage.jst.go.jp
Emphysematous cystitis (EC) is a rare form of complicated urinary tract infection, its
characteristic feature being gas within the bladder wall and lumen. Patients with EC present with …

[HTML][HTML] Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals

K Maeda, M Amano, Y Uemura, K Tsuchiya… - Scientific Reports, 2021 - nature.com
While mRNA vaccines against SARS-CoV-2 are exceedingly effective in preventing
symptomatic infection, their immune response features remain to be clarified. In the present …

[HTML][HTML] Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization

Y Koh, S Matsumi, D Das, M Amano, DA Davis… - Journal of biological …, 2007 - ASBMB
Dimerization of HIV-1 protease subunits is essential for its proteolytic activity, which plays a
critical role in HIV-1 replication. Hence, the inhibition of protease dimerization represents a …

Mondor's disease: a review of the literature

M Amano, T Shimizu - Internal Medicine, 2018 - jstage.jst.go.jp
Mondor’s disease (MD) is a rare disease that manifests with a palpable cord-like induration
on the body surface. In general, MD is a self-limited, benign thrombophlebitis that resolves in …

Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4′-ethynyl-2-fluoro-2′-deoxyadenosine

H Nakata, M Amano, Y Koh, E Kodama… - Antimicrobial agents …, 2007 - Am Soc Microbiol
We examined the intracytoplasmic anabolism and kinetics of antiviral activity against human
immunodeficiency virus type 1 (HIV-1) of a nucleoside reverse transcriptase inhibitor, 4′-…

In Vitro Selection of Highly Darunavir-Resistant and Replication-Competent HIV-1 Variants by Using a Mixture of Clinical HIV-1 Isolates Resistant to Multiple …

Y Koh, M Amano, T Towata, M Danish… - Journal of …, 2010 - Am Soc Microbiol
We attempted to select HIV-1 variants resistant to darunavir (DRV), which potently inhibits
the enzymatic activity and dimerization of protease and has a high genetic barrier to HIV-1 …

Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence

…, K Takemoto, M Watanabe, M Amano… - Proceedings of the …, 2021 - National Acad Sciences
Human retroviruses, including human T cell leukemia virus type 1 (HTLV-1) and HIV type 1 (HIV-1),
encode an antisense gene in the negative strand of the provirus. Besides coding for …

Design and Synthesis of Potent HIV-1 Protease Inhibitors Incorporating Hexahydrofuropyranol-Derived High Affinity P2 Ligands: Structure−Activity Studies and …

…, MP Steffey, DE Walters, Y Koh, M Amano… - Journal of medicinal …, 2011 - ACS Publications
The design, synthesis, and evaluation of a new series of hexahydrofuropyranol-derived HIV-1
protease inhibitors are described. We have designed a stereochemically defined …

[PDF][PDF] 4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus

…, K Singh, D Das, DJ Venzon, M Amano… - …, 2015 - Wiley Online Library
Certain nucleoside/nucleotide reverse transcriptase (RT) inhibitors (NRTIs) are effective
against human immunodeficiency virus type 1 (HIV‐1) and hepatitis B virus (HBV). However, …

[HTML][HTML] Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa …

M Amano, S Otsu, K Maeda, Y Uemura, Y Shimizu… - Scientific Reports, 2022 - nature.com
In the present prospective study, 225 individuals in Kumamoto General Hospital, Japan, who
received two-doses of BNT162b2 vaccine were enrolled/followed up over 150 days and …